Abstract
DBD (1,6,Dibromo-1,6,Dideoxydulcitol) is a cytostatic sugar-alcohol derivative. It was synthetized by Horvath and Institoris in the Chinoin Pharmaceutical Factory in Hungary. DBD is a stereoisomeric variant of another Hungarian drug, Dibromomannitol or Myelobromol. The position of the hydroxyl-groups is the difference between the two compounds.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Hindy, I., Szanto, J. (1976). Clinical Investigations of Dibromodulcitol in the Treatment of Malignant Diseases. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Chemotherapy, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4352-3_72
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4352-3_72
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4354-7
Online ISBN: 978-1-4613-4352-3
eBook Packages: Springer Book Archive